Neil A. Klompas, Chief Financial Officer at Zymeworks Inc. (ZYME), sold 15,012 shares at $19.22 ($289K) on 2019-05-06, disclosed to the SEC on 2019-05-08.
Open-market sale of $289k ZYME by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.22 | 6,704 | $129K | 44.7% |
| 2 | $19.22 | 6,704 | $129K | 44.7% |
| 3 | $19.25 | 1,604 | $31K | 10.7% |
| Total | $19.22 avg | 15,012 | $289K | 100% |
| Filing → |
| ZYME | SELL | 2021-03-12 | $50K | — | Filing → |
| ZYME | SELL | 2020-12-11 | $1.3M | — | Filing → |